Infographics

June 11, 2019

Is AML Treatment Landscape At A Tipping Point?

The recent flurry of drug approvals has markedly altered the treatment landscape in AML providing patients with new opportunities. The space is getting more exciting as improved genetic testing, combinations of targeted therapies, and the advancement of immunotherapies will finally provide physicians options to advance beyond Walkman-era treatments.
Read More
August 16, 2018

Evolution In EGFRM+ Lung Cancer

Interest in the EGFR Lung cancer space initially started with the isolation of Epidermal growth factor (EGF) gene by Stanley Cohen in 1962 as a protein extracted from the mouse submaxillary gland that accelerated incisor eruption. Therefore, it was originally termed ‘tooth-lid factor’, but was later renamed EGF because it stimulated the proliferation of epithelial cells. Since then substantial progress has been made against lung cancer over the last two decades. Research has also powered the emergence of new targeted treatments which are helping patients live a longer and higher quality life after a lung cancer diagnosis. This infographic allows the reader to dwell deeper and look closely into the history of discovery, evolution and advancements pertaining to EGFR lung cancer space.
Read More
July 17, 2018

Top 20 Pharmaceutical Brands

An overview of the top 20 pharmaceutical products/brands based on sales of 2017.
Read More
July 10, 2018

Immunotherapy Biomarkers

Cancer immunotherapy has provided substantial clinical benefit in a significant number of patients with advanced disease. However, the need for more precise immunotherapies and predictive biomarkers remains pressing. This infographics contains a timeline on immunotherapy related biomarkers developed so far.
Read More
July 10, 2018

Top 20 pharma companies of 2018

An overview of the top 20 global pharmaceutical companies of 2018, with a quick glance into the top 10.
Read More
June 4, 2018

Major Milestones in Cancer Research

Research and development within the cancer field is continuously evolving and progressing. This infographic highlights the biggest milestones within the field of cancer research spanning 170 years —from the advent of general anesthesia opening the door for cancer surgery in the mid-1800s to the first gene therapy for cancer approved by the Food and Drug Administration in 2017.
Read More
February 13, 2018

Sickness 2030

A brief overview of the major mortality drivers in 2030 by age and gender
Read More
December 21, 2017

Entrepreneur Cafe

Indian start-up ecosystem has been steadily growing with over 5200 start-ups in the country today. India has become the world’s third-largest start-up ecosystem, and is projected to cross 10,000 by 2020! This infographic throws light on the healthcare (health-tech) start-up landscape of the country and provides an overview of the funding scenario, government initiatives, start-up hotspots, categorization of start-ups based on service offerings and some interesting examples.
Read More
September 12, 2017

Immuno-Oncology Therapies In Renal Cell Carcinoma

A quick overview on the I/O Therapies In Renal Cell Carcinoma
Read More
May 21, 2017

A Quick Overview on FDA Drug Approvals

A quick overview on the novel drug approvals by the FDA over the last 5 years.
Read More
May 10, 2017

Infographic – Company Profile (BMS)

Infographics: 6 Frames - BMS
Read More
April 14, 2017

Digital Healthcare – An Era of Healthcare Revolution

Digital technologies are revolutionizing the healthcare industry. In 2020, this market is estimated to reach $200B. These technologies have reinvented the healthcare across the patient lifecycle. With the emergence of smarter devices, mobile solutions and patient-centered technologies, the healthcare industry is transforming from disease management to disease prevention.
Read More
April 12, 2017

Malignant Pleural Mesothelioma – Treatment Landscape & Future Outlook

Malignant Pleural mesothelioma is a relatively rare but aggressive form of cancer with very poor prognosis. Platinum-based chemotherapy has been the only therapeutic option in first-line. Currently, the efficacy of second-line therapy remains unproven and is a major unmet need. The diagnostic markers too lack specificity and are yet not effective to detect mesothelioma in early stages. This infographic highlights the types of pleural mesothelioma, current clinical research, biomarkers and future outlook.
Read More
April 6, 2017

Infographic – Basic Facts on Mesothelioma

Mesothelioma, considered as a rare and occupational related cancer, is likely to become more common due to increasing exposure to Asbestos. Several countries are yet to see the peak incidence, whereas in some countries it is misdiagnosed or under reported. This infographic attempts to provide the basic statistics around Mesothelioma to understand the impact of this disease on an individual and country level.
Read More
March 30, 2017

Infographic – Beyond-the-Pill (BTP)

One size no longer fits all! Pharmaceutical companies are finally moving towards ‘beyond the pill’ strategy to deliver patient-centric outcomes. Today, companies are developing and providing tailored solutions either in-house or in collaborations to implement technology solutions that will ultimately improve health outcomes and foster stronger relationships between all stakeholders.
Read More
March 3, 2017

Infographic – Company Profile (Roche)

Infographics: 6 Frames - Roche
Read More
February 23, 2017

Infographic – Drug Development Process

From Laboratory Bench to Bedside: the process of developing a new medicine is a complex, time consuming and costly affair. It takes between 10-12 years to move a potential drug from concept to market and can cost the pharmaceutical industry around $2.5B including cost of failures.
Read More
February 23, 2017

Infographic – The World of Anticoagulants

There is no doubt that VKAs (Warfarin) have been used since over 50 years for the management of stroke prevention in Non-Valvular Atrial Fibrillation and Venous Thromboembolism. However, the emergence of non-vitamin K oral anticoagulants such as Pradaxa, Xarelto, Eliquis and Lixiana have changed the landscape of thromboprophylaxis.
Read More